Davidson Kempner Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Davidson Kempner Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-195,000	Closed	-$11.5M	–	268
2020 Q2	$11.5M	Buy	+195,000	New	+$11.7M	0.28%	100
2019 Q4	–	Sell	-20,275	Closed	-$1.03M	–	167
2019 Q3	$1.03M	Buy	+20,275	New	+$953K	0.02%	134
2014 Q2	–	Sell	-201,000	Closed	-$10.4M	–	144
2014 Q1	$10.4M	Buy	+201,000	New	+$10.7M	0.38%	61

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Davidson Kempner Capital Management's BMY Position: Q3 2020 in Review

Davidson Kempner Capital Management sold out of Bristol-Myers Squibb (BMY) in Q3 2020, closing a stake of 195,000 shares — an estimated $11.5M sold.

Davidson Kempner Capital Management first reported a position in BMY in Q1 2014 and held it in 3 quarters. The position peaked at $11.5M in Q2 2020. 2,214 funds tracked by Wall St. Rank hold BMY as of Q3 2020.

Davidson Kempner Capital Management reported no remaining Bristol-Myers Squibb position as of Q3 2020 after selling out during the quarter.
Davidson Kempner Capital Management sold 195,000 Bristol-Myers Squibb shares in Q3 2020, an estimated $11.5M.
Davidson Kempner Capital Management first reported a position in Bristol-Myers Squibb in Q1 2014 and held it in 3 quarters.
Davidson Kempner Capital Management's Bristol-Myers Squibb position peaked at $11.5M in Q2 2020.
2,214 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2020.

Based on Davidson Kempner Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.